In accordance with Section 28(a) of the Danish Securities Trading Act, BioPorto is required to publish details of the transactions in BioPorto's shares and related securities effected by senior management and their connected persons. Name Peter Nordkild Reason Member of the Board of Directors Issuer BioPorto A/S ISIN code DK0011048619 Designation Shares Transaction Buy Trade date December 22, 2008 Market Copenhagen Stock Exchange Number 7,000 Share price in DKK 38,500 For further information please contact: Christina Tønnesen, Investor Relations Tel. +45 45 29 00 00, e-mail investor@bioporto.com
Attachments
Recommended Reading
-
March 31, 2026Announcement no. 6 BioPorto Advances U.S. Adult Urine NGAL Program with FDA Pre-Submission Request After Positive EPACRA AKI Cut Off Analysis COPENHAGEN, DENMARK, 31 March 2026 –...
Read More -
March 31, 2026News Release KDIGO publishes 2026 Clinical Practice Guideline Draft for Acute Kidney Injury and Acute Kidney Disease COPENHAGEN, DENMARK, 31 March 2026 – BioPorto A/S (“BioPorto” or...
Read More